Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Debt Issued

Adverum Biotechnlgs Debt Issued Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Debt Issued from 2013 to 2018.
  • Adverum Biotechnlgs Debt Issued for the quarter ending December 12, 2018 was $0m a 0.00% decrease of 0m year over year
  • Adverum Biotechnlgs Debt Issued for the last 12 months ending September 09, 2019 was $0m a 0.00% decrease of 0m year over year
  • Adverum Biotechnlgs Annual Debt Issued for 2018 was $0m a 0.00% decrease of 0m from 2017
  • Adverum Biotechnlgs Annual Debt Issued for 2016 was $0m a -1,900.00% decrease of -2m from 2015
  • Adverum Biotechnlgs Annual Debt Issued for 2014 was $2m a 25.00% increase of 1m from 2013
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Debt Issued Data

12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m
12/2016$0m
09/2016$0m
12/2014$0m
09/2014$0m
06/2014$1m
03/2014$1m

Annual ADVM Debt Issued Data

2018$0m
2016$0m
2014$2m
2013$2m
2012$1m